Pfizer Says Its Vaccine Is Highly Protective in Children 5 to 11
By BY SHARON LAFRANIERE AND NOAH WEILAND
U.S.
https://ift.tt/3pqqcHu
The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps next week, a long-awaited development that would affect 28 million children.
New York Times
Clinical Trials, Coronavirus (2019-nCoV), Vaccination and Immunization, Children and Childhood, Drugs (Pharmaceuticals)
October 22, 2021 at 11:39PM